MAPT and Mental deterioration: Cortical thickness changes accurately track cognitive changes but may be confounded by pseudo-atrophy in anti-Aβ treatments.<h4>Highlights</h4>Longitudinal changes in tau-PET, plasma p-tau<sub>217</sub>, cortical thickness - but not amyloid-PET - effectively track cognitive decline.